Detalles de la búsqueda
1.
Palliative home care for patients with advanced haematological malignancies-a multicenter survey.
Ann Hematol
; 96(9): 1557-1562, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28638954
2.
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
Int J Cancer
; 138(3): 739-46, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26284333
3.
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Ann Oncol
; 27(8): 1565-72, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27234640
4.
Treatment of older patients with mantle-cell lymphoma.
N Engl J Med
; 367(6): 520-31, 2012 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22873532
5.
[The Oncologic and Palliative Network Landshut: a problem-solving approach to oncological and palliative care in structurally weak rural areas, with special emphasis on outpatient and inpatient networking]. / Das Onkologische und Palliativmedizinische Netzwerk Landshut. Lösungsansatz für die zukünftige ambulante und stationäre Versorgung von onkologischen und palliativmedizinischen Patienten in strukturschwachen ländlichen Gebieten.
MMW Fortschr Med
; 156 Suppl 3: 79-83, 2014 Oct 09.
Artículo
en Alemán
| MEDLINE | ID: mdl-25417445
6.
[The Oncologic and Palliative Network Landshut: a problem-solving approach to oncological and palliative care in structurally weak rural areas, with special emphasis on outpatient and inpatient networking]. / Das Onkologische und Palliativmedizinische Netzwerk Landshut. Lösungsansatz für die zukünftige ambulante und stationäre Versorgung von onkologischen und palliativmedizinischen Patienten in strukturschwachen ländlichen Gebieten.
MMW Fortschr Med
; 156 Suppl 3: 79-83, 2014 Oct 09.
Artículo
en Alemán
| MEDLINE | ID: mdl-25507173
7.
Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).
ESMO Open
; 9(5): 103374, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744100
8.
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.
Br J Cancer
; 108(2): 469-76, 2013 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23169292
9.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306.
Ann Oncol
; 23(7): 1693-9, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22219013
10.
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
ESMO Open
; 7(1): 100391, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149429
11.
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial.
Br J Cancer
; 105(2): 206-11, 2011 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750558
12.
A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer.
Ann Oncol
; 22(3): 603-608, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20724574
13.
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Eur J Cancer
; 106: 115-125, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30496943
14.
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status.
Crit Rev Oncol Hematol
; 66(1): 84-90, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18243012
15.
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.
Oncology
; 73(5-6): 407-14, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18515981
16.
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306).
Eur J Cancer
; 84: 262-269, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28843184
17.
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.
Eur J Cancer
; 79: 50-60, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463756
18.
Nutrition care in patients with cancer: A retrospective multicenter analysis of current practice - Indications for further studies?
Clin Nutr
; 34(2): 207-11, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679553
19.
Low-dose cytosine arabinoside (LD-Ara C) treatment in dysmyelopoietic syndromes (DMPS) and acute myelogenous leukemia (AML).
Anticancer Res
; 7(3 Pt B): 505-8, 1987.
Artículo
en Inglés
| MEDLINE | ID: mdl-3477124
20.
A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions.
Curr Med Res Opin
; 30(9): 1813-20, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24849527